Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
[HTML][HTML] Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer
BL Horton, DM Morgan, N Momin, M Zagorulya… - Science …, 2021 - ncbi.nlm.nih.gov
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer.
BL Horton, DM Morgan, N Momin… - Science …, 2021 - search.ebscohost.com
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
[引用][C] Lack of CD8 + T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer
BL Horton, DM Morgan, N Momin, M Zagorulya… - Science …, 2021 - cir.nii.ac.jp
Lack of CD8 <sup>+</sup> T cell effector differentiation during priming mediates checkpoint
blockade resistance in non–small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術 …
blockade resistance in non–small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術 …
Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer
BL Horton, DM Morgan, N Momin… - Science …, 2021 - pubmed.ncbi.nlm.nih.gov
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer.
BL Horton, DM Morgan, N Momin, M Zagorulya… - Science …, 2021 - europepmc.org
In non–small cell lung cancer (NSCLC), response to immune checkpoint blockade (ICB) is
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …
associated with programmed cell death ligand 1 expression that is induced by interferon-γ …